本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kura Oncology, Inc

13.62
+1.229.84%
成交量:330.21萬
成交額:4,456.02萬
市值:12.09億
市盈率:-4.05
高:13.90
開:13.59
低:12.85
收:12.40
52周最高:13.90
52周最低:7.36
股本:8,877.44萬
流通股本:7,060.22萬
量比:2.10
換手率:4.68%
股息:- -
股息率:- -
每股收益(TTM):-3.3668
每股收益(LYR):-3.1784
淨資產收益率:-167.71%
總資產收益率:-31.30%
市淨率:24.97
市盈率(LYR):-4.29

資料載入中...

2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

重要事件披露

Form 8-K - Current report
2025/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

重要事件披露

Form 8-K - Current report
2025/11/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/04

重要事件披露

Form 8-K - Current report
2025/10/24

重要事件披露

Form 8-K - Current report